Publications
2022
Investigation of variable therapy outcomes in chronic lymphocytic leukaemia using a proteomics approach
Khan, U. (2022, December 2). Investigation of variable therapy outcomes in chronic lymphocytic leukaemia using a proteomics approach.
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Wysocki, O., Zhou, C., Rogado, J., Huddar, P., Shotton, R., Tivey, A., . . . Co-Care, E. S. M. O. (2022). An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves. Cancers, 14(16). doi:10.3390/cancers14163931
2021
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
Khan, U. T., Kelly, M., Dodd, J., Fergiani, S., Hammer, B., Smith, J., . . . Menon, G. (2021). Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study. JOURNAL OF CLINICAL PATHOLOGY, 74(12), 816-818. doi:10.1136/jclinpath-2020-207121
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
Lee, R. J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., . . . Armstrong, A. C. (2021). Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome. ESMO OPEN, 6(1). doi:10.1016/j.esmoop.2020.100005
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Bhogal, T., Khan, U. T., Lee, R., Stockdale, A., Hesford, C., Potti-Dhananjaya, V., . . . Palmieri, C. (2021). Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.. Leukemia & lymphoma, 1-16. doi:10.1080/10428194.2021.1876865
Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia
Mohammad, I., Lin, K., Oates, M., Khan, U., Burger, J., Pettitt, A., & Zhuang, J. (2020). Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia. Leukemia and Lymphoma. doi:10.1080/10428194.2020.1811274
2020
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.. Haematologica, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial. HAEMATOLOGICA, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805
2018
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis
Khan, U. T., Racu-Amoasii, I., Arumainathan, A., Meswani, U., Pettitt, A. R., & Menon, G. (2018). Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis. BRITISH JOURNAL OF HAEMATOLOGY, 183(3), 345. doi:10.1111/bjh.15489
2017
Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis
Khan, U. T., Walker, A. J., Baig, S., Card, T. R., Kirwan, C. C., & Grainge, M. J. (2017). Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis. BMC CANCER, 17. doi:10.1186/s12885-017-3719-1
2015
PEGylated IFNβ-1a in the treatment of multiple sclerosis.
Khan, U. T., Tanasescu, R., & Constantinescu, C. S. (2015). PEGylated IFNβ-1a in the treatment of multiple sclerosis.. Expert opinion on biological therapy, 15(7), 1077-1084. doi:10.1517/14712598.2015.1053206
2014
Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients.
Gupta, S., Hartley, R., Khan, U. T., Singapuri, A., Hargadon, B., Monteiro, W., . . . Brightling, C. E. (2014). Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients.. The Journal of allergy and clinical immunology, 133(3), 729-38.e18. doi:10.1016/j.jaci.2013.09.039
2012
A Novel, Safe Way of Removing Non-Deflatable Bladder Catheter
Khan, Z., Tahir Khan, U., Khan, I., & Naeem Khan, T. (2012). A Novel, Safe Way of Removing Non-Deflatable Bladder Catheter. Open Journal of Urology, 02(04), 243-245. doi:10.4236/oju.2012.24044